$200M Generic Drug Settlement (Sun/Taro): How to Claim

What happened

Class period: May 1, 2009 through December 31, 2019

• A group of class actions, In re Generic Pharmaceuticals Pricing Antitrust Litigation, Case No. 2:16-MD-02724, is pending in the U.S. District Court for the Eastern District of Pennsylvania
• The lawsuit claims generic drug makers fixed prices, rigged bids, and split up customers and markets for certain generic drugs
• The lawsuit says this caused consumers and third-party payers, such as insurers and self-funded health plans, to overpay for those drugs from May 1, 2009 to December 31, 2019
• Sun Pharmaceutical Industries, Inc. and Taro Pharmaceuticals U.S.A., Inc. (Sun/Taro) agreed to pay $200 million to settle the claims against them
• Sun/Taro deny liability, and no trial has been held
• The Court has granted final approval of the Sun/Taro settlement
• The lawsuit continues against the other drug makers that have not settled

What you can get

Key dates

Who may qualify

• You are a consumer who bought a Named Generic Drug at a pharmacy or by mail order, or a third-party payer that paid or reimbursed for one
• You made the purchase between May 1, 2009 and December 31, 2019
• You were in any U.S. state except Indiana and Ohio, or in the District of Columbia, Puerto Rico, or the U.S. Virgin Islands
• You bought the drug for use, not for resale
• Purchases covered by Medicaid do not count
• Federal and state government entities, pharmacy benefit managers, and fully insured employers (for their fully insured plans) are excluded
• Cities, counties, and other local governments with self-funded drug plans are included

How to file

1. Check if your drug is on the Named Generic Drugs list, or use the drug lookup tool on the official website
2. Get the Claim Form from the official homepage, or call 1-877-316-0171 to have one mailed to you
3. Submit the Claim Form online by November 9, 2026
4. Or mail the Claim Form so it is postmarked by November 9, 2026
5. You do not need to sign up with or pay a claims recovery firm to file

Proof required

• Proof requirements are listed on the Claim Form; check the official website for details
• The Notice asks you to confirm from your own records that you paid for a Named Generic Drug between May 1, 2009 and December 31, 2019
• You do not need to calculate your own payment amount

Payment timing

Payments will be sent after the Court allows the fund to be distributed. Timing depends on appeals and the approval of other settlements in the case. The payment method is not listed on the settlement website.

Important links

• Official website
• Important dates
• FAQs
• Documents

Contact

Extra details

• Sun/Taro paid $200,000,000 into an escrow account; the fund may be reduced by up to $10,000,000 under certain conditions
• Deductions include notice and administration costs (up to $750,000), attorneys' fees (up to 1/3 of the fund plus interest), litigation expenses (up to $4,000,000), and service awards (up to $500,000 total)
• Payments are pro rata, so people who spent more on the listed drugs get more
• If fewer people file, each claimant could get a larger share
• Interest earned on the fund is added to payments
• If you opted out of the earlier Sandoz, Heritage, or Apotex settlements, or the Clobetasol or Clomipramine classes, you can still file here
• If your request to opt out of this settlement was approved, you cannot get a payment
• The release may affect your ability to recover against Sun/Taro in some state Attorney General cases; see www.AGGenericDrugs.com
• A Spanish notice is available by calling 1-877-316-0171
• Do not call the Court or the Clerk's office about this settlement

FAQ

Related guides